FANG Yiwei
Zunyi Medical University, Zunyi, Guizhou 563006, ChinaKUANG Chunyan
Zunyi Medical University, Zunyi, Guizhou 563006, China;Cardiovascular Department of Guizhou Provincial People’s Hospital, Guiyang, Guizhou 550002, China1.Zunyi Medical University, Zunyi, Guizhou 563006, China;2.Cardiovascular Department of Guizhou Provincial People’s Hospital, Guiyang, Guizhou 550002, China)
R5
Renal arterial stenosis (RAS) hypertension is one of the common types of secondary hypertension. The main clinical manifestations are increased levels of renin and aldosterone, abnormal renal function and refractory hypertension that is difficult to control by drugs. In this paper, a case with refractory hypertension due to atherosclerotic renal artery stenosis was reported and the relevant literature was reviewed. The patient was a middle-aged male who could not control his blood pressure within the ideal range despite oral administration of amlodipinebesylate, terazosinhydrochloride, irbesartan, carvedilol, metoprololsuccinate, diltiazium hydrochloride and other drugs, requiring continuous pumping of nitroglycerin to lower blood pressure. Furthermore, the examination of renal artery angiography revealed severe stenosis at the origin of the left renal artery. After stent implantation at the renal artery stenosis, blood pressure could be controlled to the standard by oral administration of terazosin hydrochloride, amlodipine besylate and diltiazem hydrochloride only. There are many reasons leading to secondary hypertension. This paper discusses the common causes of renal artery stenosis as a starting point, in order to deepen the understanding of secondary hypertension and reduce the occurrence of missed diagnosis or misdiagnosis.
FANG Yiwei, KUANG Chunyan. Refractory hypertension induced by left renal artery stenosis in middle-aged individuals:a case report and literature review[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2025,33(3):251-256.
Copy
You are the 69448 visitor
Post Code:421001 Fax:0734-8160523
Phone:0734-8160765 E-mail:dmzzbjb@163.net
Editorial Office of Chinese Journal of Arteriosclerosis ® 2025